SCHEMBL6937580

SCHEMBL6937580

NC1=NC(CF)(c2cc(NC(=O)c3ccc(N)cn3)ccc2F)COC1

nearest known ligand 0.86

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.86
BACE2 Q9Y5Z0 2/20 0.65
APP P05067 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL360873 0.93 BACE1 (1.00) BACE1BACE2
SCHEMBL361102 0.93 BACE1 (1.00) BACE1BACE2
Hydrochloric Acid SCHEMBL361858 0.92 BACE1 (0.98) BACE1BACE2
SCHEMBL361485 0.91 BACE1 (1.00) BACE1BACE2APP
SCHEMBL14135735 0.89 BACE1 (0.81) BACE1BACE2
SCHEMBL361710 0.89 BACE1 (1.00) BACE1
SCHEMBL1910632 0.85 BACE1 (0.86) BACE1APP
SCHEMBL362498 0.85 BACE1 (1.00) BACE1
SCHEMBL363629 0.84 BACE1 (1.00) BACE1BACE2
SCHEMBL360383 0.84 BACE1 (1.00) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011009943-A1 OXAZINE DERIVATIVES AND THEIR USE AS BACE INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2011-01-27 WO disclosed